Autoimmunity in 2012

Clinical Reviews in Allergy and Immunology

Volumn 45, Issue 2, 2013, Pages 290-301

  Selmi, Carlo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Connective tissue disease; IL12; Immune tolerance; Th17; Vitamin D

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; BIOLOGICAL MARKER; CYTOKINE; TRANSFORMING GROWTH FACTOR BETA;

ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CHEMOTAXIS; CLONAL ANERGY; ENVIRONMENTAL FACTOR; EPIGENETICS; GENETIC SUSCEPTIBILITY; GENITAL SYSTEM; GENOME; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; SEX; SEX CHROMOSOME; SIGNAL TRANSDUCTION; TH17 CELL;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; BIOMEDICAL RESEARCH; DISEASE MODELS, ANIMAL; FEMALE; GENE-ENVIRONMENT INTERACTION; HISTORY, 21ST CENTURY; HUMANS; INTERFERON-ALPHA; MOLECULAR TARGETED THERAPY; SEX FACTORS; SIGNAL TRANSDUCTION; TH17 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84884902115     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-013-8386-7     Document Type: Review

References (230)

1. Selmi C (2012) Autoimmunity in 2011. Clin Rev Allergy Immunol 43:194-206
2. Selmi C, Lu Q, Humble MC (2012) Heritability versus the role of the environment in autoimmunity. J Autoimmun 39:249-252
3. Singh RP, Waldron RT, Hahn BH (2012) Genes, tolerance and systemic autoimmunity. Autoimmun Rev 11:664-669
4. Greco A, Gallo A, Fusconi M, Marinelli C, Macri GF, de Vincentiis M (2012) Bell's palsy and autoimmunity. Autoimmun Rev 12:323-328
5. Perricone C, Shoenfeld N, Agmon-Levin N, de Carolis C, Perricone R, Shoenfeld Y (2012) Smell and autoimmunity: a comprehensive review. Clin Rev Allergy Immunol 13:13
6. Bijl M, Agmon-Levin N, Dayer JM, Israeli E, Gatto M, Shoenfeld Y (2012) Vaccination of patients with auto-immune inflammatory rheumatic diseases requires careful benefit-risk assessment. Autoimmun Rev 11:572-576
7. Fierabracci A, Milillo A, Locatelli F, Fruci D (2012) The putative role of endoplasmic reticulum aminopeptidases in autoimmunity: insights from genomic-wide association studies. Autoimmun Rev 12:281-288
8. Gianchecchi E, Palombi M, Fierabracci A (2012) The putative role of the C1858T polymorphism of protein tyrosine phosphatase PTPN22 gene in autoimmunity. Autoimmunity reviews 20:294-297
9. Amur S, Parekh A, Mummaneni P (2012) Sex differences and genomics in autoimmune diseases. J Autoimmun 38:J254-265
10. Ice JA, Li H, Adrianto I et al (2012) Genetics of Sjogren's syndrome in the genome-wide association era. J Autoimmun 39:57-63
11. Bogdanos DP, Smyk DS, Rigopoulou EI et al (2012) Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun 38:J156-169
12. Xia Z, Liu Q, Berger CT et al (2012) A 17q12 allele is associated with altered NK cell subsets and function. J Immunol 188:3315-3322
13. Ngalamika O, Zhang Y, Yin H, Zhao M, Gershwin ME, Lu Q (2012) Epigenetics, autoimmunity and hematologic malignancies: a comprehensive review. J Autoimmun 39:451-465
14. Mailloux AW, Sugimori C, Komrokji RS et al (2012) Expansion of effector memory regulatory T cells represents a novel prognostic factor in lower risk myelodysplastic syndrome. J Immunol 189:3198-3208
15. De Santis M, Selmi C (2012) The therapeutic potential of epigenetics in autoimmune diseases. Clin Rev Allergy Immunol 42:92-101
16. Selmi C, Leung PS, Sherr DH et al (2012) Mechanisms of environmental influence on human autoimmunity: a national institute of environmental health sciences expert panel workshop. J Autoimmun 39:272-284
17. Barzaghi F, Passerini L, Gambineri E et al (2012) Demethylation analysis of the FOXP3 locus shows quantitative defects of regulatory T cells in IPEX-like syndrome. J Autoimmun 38:49-58
18. Pollard KM (2012) Gender differences in autoimmunity associated with exposure to environmental factors. J Autoimmun 38:J177-186
19. Selmi C, Brunetta E, Raimondo MG, Meroni PL (2012) The X chromosome and the sex ratio of autoimmunity. Autoimmun Rev 11:A531-537
20. Bianchi I, Lleo A, Gershwin ME, Invernizzi P (2012) The X chromosome and immune associated genes. J Autoimmun 38:J187-192
21. Persani L, Bonomi M, Lleo A et al (2012) Increased loss of the Y chromosome in peripheral blood cells in male patients with autoimmune thyroiditis. J Autoimmun 38:J193-196
22. Zhou R, Horai R, Silver PB et al (2012) The living eye disarms uncommitted autoreactive T cells by converting them to Foxp3(+) regulatory cells following local antigen recognition. J Immunol 188:1742-1750
23. Silva CA, Cocuzza M, Borba EF, Bonfa E (2012) Cutting-edge issues in autoimmune orchitis. Clin Rev Allergy Immunol 42:256-263
24. Vergani D, Mieli-Vergani G (2012) Cutting edge issues in autoimmune hepatitis. Clin Rev Allergy Immunol 42:309-321
25. Murthy A, Shao YW, Defamie V, Wedeles C, Smookler D, Khokha R (2012) Stromal TIMP3 regulates liver lymphocyte populations and provides protection against Th1 T cell-driven autoimmune hepatitis. J Immunol 188:2876-2883
26. Munoz LE, Herrmann M (2012) When autologous chromatin becomes a foe. Autoimmunity 45:565-567
27. Temajo NO, Howard N (2012) The viral enterprises in autoimmunity: conversion of target cells into de novo APCs is the presage to autoimmunity. Autoimmun Rev 11:653-658
28. Nahum A, Dadi H, Bates A, Roifman CM (2012) The biological significance of TLR3 variant, L412F, in conferring susceptibility to cutaneous candidiasis, CMV and autoimmunity. Autoimmun Rev 11:341-347
29. Guerrier T, Youinou P, Pers JO, Jamin C (2012) TLR9 drives the development of transitional B cells towards the marginal zone pathway and promotes autoimmunity. J Autoimmun 39:173-179
30. Arcipowski KM, Bishop GA (2012) TRAF binding is required for a distinct subset of in vivo B cell functions of the oncoprotein LMP1. J Immunol 189:5165-5170
31. Crampton SP, Deane JA, Feigenbaum L, Bolland S (2012) Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity. J Immunol 188:1451-1459
32. Isakson SH, Katzman SD, Hoyer KK (2012) Spontaneous autoimmunity in the absence of IL-2 is driven by uncontrolled dendritic cells. J Immunol 189:1585-1593
33. Pollard KM, Hultman P, Toomey CB et al (2012) Definition of IFN-gamma-related pathways critical for chemically-induced systemic autoimmunity. J Autoimmun 39:323-331
34. Xu WD, Pan HF, Ye DQ, Xu Y (2012) Targeting IRF4 in autoimmune diseases. Autoimmun Rev 11:918-924
35. Smyk D, Rigopoulou EI, Baum H, Burroughs AK, Vergani D, Bogdanos DP (2012) Autoimmunity and environment: am I at risk? Clin Rev Allergy Immunol 42:199-212
36. Miller FW, Pollard KM, Parks CG et al (2012) Criteria for environmentally associated autoimmune diseases. J Autoimmun 39:253-258
37. Miller FW, Alfredsson L, Costenbader KH et al (2012) Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun 39:259-271
38. Germolec D, Kono DH, Pfau JC, Pollard KM (2012) Animal models used to examine the role of the environment in the development of autoimmune disease: findings from an NIEHS Expert Panel Workshop. J Autoimmun 39:285-293
39. Lau M, Tsantikos E, Maxwell MJ, Tarlinton DM, Anderson GP, Hibbs ML (2012) Loss of STAT6 promotes autoimmune disease and atopy on a susceptible genetic background. J Autoimmun 39:388-397
40. Bogdanos DP, Smyk DS, Invernizzi P et al (2012) Infectome: a platform to trace infectious triggers of autoimmunity. Autoimmunity reviews 22:296-300
41. Moroni L, Bianchi I, Lleo A (2012) Geoepidemiology, gender and autoimmune disease. Autoimmun Rev 11:A386-392
42. Yeter D, Deth R (2012) ITPKC susceptibility in Kawasaki syndrome as a sensitizing factor for autoimmunity and coronary arterial wall relaxation induced by thimerosal's effects on calcium signaling via IP3. Autoimmun Rev 11:903-908
43. Sibilano R, Frossi B, Calvaruso M et al (2012) The aryl hydrocarbon receptor modulates acute and late mast cell responses. J Immunol 189:120-127
44. Antico A, Tampoia M, Tozzoli R, Bizzaro N (2012) Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev 12:127-136
45. Ohno S, Yu H, Dickinson D et al (2012) Epigallocatechin-3-gallate modulates antioxidant and DNA repair-related proteins in exocrine glands of a primary Sjogren's syndrome mouse model prior to disease onset. Autoimmunity 45:540-546
46. Tzioufas AG, Kapsogeorgou EK, Moutsopoulos HM (2012) Pathogenesis of Sjogren's syndrome: what we know and what we should learn. J Autoimmun 39:4-8
47. Tzioufas AG, Vlachoyiannopoulos PG (2012) Sjogren's syndrome: an update on clinical, basic and diagnostic therapeutic aspects. J Autoimmun 39:1-3
48. Oke V, Wahren-Herlenius M (2012) The immunobiology of Ro52 (TRIM21) in autoimmunity: a critical review. J Autoimmun 39:77-82
49. Selmi C (2012) Cutting-edge issues in autoimmunity and allergy of the digestive system. Clin Rev Allergy Immunol 42:265-268
50. Recalcati S, Locati M, Gammella E, Invernizzi P, Cairo G (2012) Iron levels in polarized macrophages: regulation of immunity and autoimmunity. Autoimmun Rev 11:883-889
51. Zizzo G, Hilliard BA, Monestier M, Cohen PL (2012) Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J Immunol 189:3508-3520
52. Fransen JH, Berden JH, Koeter CM, Adema GJ, Van Der Vlag J, Hilbrands LB (2012) Effect of administration of apoptotic blebs on disease development in lupus mice. Autoimmunity 45:290-297
53. Bouts YM, Wolthuis DF, Dirkx MF et al (2012) Apoptosis and NET formation in the pathogenesis of SLE. Autoimmunity 45:597-601
54. Chighizola C, Meroni PL (2012) The role of environmental estrogens and autoimmunity. Autoimmun Rev 11:A493-501
55. Pan Z, Chang C (2012) Gender and the regulation of longevity: implications for autoimmunity. Autoimmun Rev 11:A393-403
56. Longo DM, Louie B, Putta S et al (2012) Single-cell network profiling of peripheral blood mononuclear cells from healthy donors reveals age- and race-associated differences in immune signaling pathway activation. J Immunol 188:1717-1725
57. Nussinovitch U, Shoenfeld Y (2012) The role of gender and organ specific autoimmunity. Autoimmun Rev 11:A377-385
58. Lee TP, Chiang BL (2012) Sex differences in spontaneous versus induced animal models of autoimmunity. Autoimmun Rev 11:A422-429
59. Eisenberg RA, Via CS (2012) T cells, murine chronic graft-versus-host disease and autoimmunity. J Autoimmun 39:240-247
60. Geurs TL, Hill EB, Lippold DM, French AR (2012) Sex differences in murine susceptibility to systemic viral infections. J Autoimmun 38:J245-253
61. Borchers AT, Gershwin ME (2012) Sociological differences between women and men: implications for autoimmunity. Autoimmun Rev 11:A413-421
62. Raaz-Schrauder D, Ekici AB, Munoz LE et al (2012) Patients with unstable angina pectoris show an increased frequency of the Fc gamma RIIa R131 allele. Autoimmunity 45:556-564
63. Ramos GC, Dalbo S, Leite DP et al (2012) The autoimmune nature of post-infarct myocardial healing: oral tolerance to cardiac antigens as a novel strategy to improve cardiac healing. Autoimmunity 45:233-244
64. Shoenfeld Y, Tincani A, Gershwin ME (2012) Sex gender and autoimmunity. J Autoimmun 38:J71-73
65. Lleo A, Moroni L, Caliari L, Invernizzi P (2012) Autoimmunity and Turner's syndrome. Autoimmun Rev 11:A538-543
66. Bakalov VK, Gutin L, Cheng CM et al (2012) Autoimmune disorders in women with turner syndrome and women with karyotypically normal primary ovarian insufficiency. J Autoimmun 38:315-321
67. Orbach H, Zandman-Goddard G, Boaz M et al (2012) Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients. Clin Rev Allergy Immunol 42:189-198
68. Shelly S, Boaz M, Orbach H (2012) Prolactin and autoimmunity. Autoimmun Rev 11:A465-470
69. Winter O, Dame C, Jundt F, Hiepe F (2012) Pathogenic long-lived plasma cells and their survival niches in autoimmunity, malignancy, and allergy. J Immunol 189:5105-5111
70. McGaha TL, Ma Z, Ravishankar B, Gabunia K, McMenamin M, Madaio MP (2012) Heterologous protein incites abnormal plasma cell accumulation and autoimmunity in MRL-MpJ mice. Autoimmunity 45:279-289
71. Carp HJ, Selmi C, Shoenfeld Y (2012) The autoimmune bases of infertility and pregnancy loss. J Autoimmun 38:J266-274
72. Twig G, Shina A, Amital H, Shoenfeld Y (2012) Pathogenesis of infertility and recurrent pregnancy loss in thyroid autoimmunity. J Autoimmun 38:J275-281
73. Cutolo M, Sulli A, Straub RH (2012) Estrogen metabolism and autoimmunity. Autoimmun Rev 11:A460-464
74. Boissier MC, Semerano L, Challal S, Saidenberg-Kermanac'h N, Falgarone G (2012) Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction. J Autoimmun 39:222-228
75. Luckey D, Medina K, Taneja V (2012) B cells as effectors and regulators of sex-biased arthritis. Autoimmunity 45:364-376
76. Kawamoto K, Pahuja A, Nettles A, Honkanen-Scott M, Bansal-Pakala P (2012) Downregulation of TGF-betaRII in T effector cells leads to increased resistance to TGF-beta-mediated suppression of autoimmune responses in type I diabetes. Autoimmunity 45:310-319
77. Smits HH (2012) B cells in allergic diseases: bad or better? Autoimmunity 45:415-426
78. Jiang C, Zhao ML, Waters KM, Diaz M (2012) Activation-induced deaminase contributes to the antibody-independent role of B cells in the development of autoimmunity. Autoimmunity 45:440-448
79. Thurner L, Preuss KD, Fadle N et al (2012) Progranulin antibodies in autoimmune diseases. Journal of autoimmunity 11:130-138
80. Marino E, Grey ST (2012) B cells as effectors and regulators of autoimmunity. Autoimmunity 45:377-387
81. Finnegan A, Ashaye S, Hamel KM (2012) B effector cells in rheumatoid arthritis and experimental arthritis. Autoimmunity 45:353-363
82. Mann MK, Ray A, Basu S, Karp CL, Dittel BN (2012) Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis. Autoimmunity 45:388-399
83. Das A, Ellis G, Pallant C et al (2012) IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol 189:3925-3935
84. Siewe B, Landay A (2012) Effector and regulatory roles for B cells in HIV infection? Autoimmunity 45:348-352
85. Hampe CS (2012) Protective role of anti-idiotypic antibodies in autoimmunity-lessons for type 1 diabetes. Autoimmunity 45:320-331
86. Mannoor K, Matejuk A, Xu Y, Beardall M, Chen C (2012) Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival. J Immunol 188:3628-3638
87. Cocco C, Meloni A, Mariotti S et al (2012) Novel neuronal and endocrine autoantibody targets in Autoimmune Polyendocrine Syndrome type 1. Autoimmunity 45:485-494
88. Hwang SH, Lee H, Yamamoto M et al (2012) B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice. J Immunol 189:5786-5796
89. Xu LG, Jin L, Zhang BC, Akerlund LJ, Shu HB, Cambier JC (2012) VISA is required for B cell expression of TLR7. J Immunol 188:248-258
90. Georg P, Bekeredjian-Ding I (2012) Plasmacytoid dendritic cells control B cell-derived IL-10 production. Autoimmunity 45:579-583
91. Gilbert MR, Wagner NJ, Jones SZ et al (2012) Autoreactive preplasma cells break tolerance in the absence of regulation by dendritic cells and macrophages. J Immunol 189:711-720
92. Kasperkiewicz M, Zillikens D, Schmidt E (2012) Pemphigoid diseases: pathogenesis, diagnosis, and treatment. Autoimmunity 45:55-70
93. Ludwig RJ (2012) Model systems duplicating epidermolysis bullosa acquisita: a methodological review. Autoimmunity 45:102-110
94. Sinha AA (2012) Constructing immunoprofiles to deconstruct disease complexity in pemphigus. Autoimmunity 45:36-43
95. Zakka LR, Reche PA, Ahmed AR (2012) The molecular basis for the presence of two autoimmune diseases occurring simultaneously-preliminary observations based on computer analysis. Autoimmunity 45:253-263
96. Zakka LR, Fradkov E, Keskin DB, Tabansky I, Stern JN, Ahmed AR (2012) The role of natural killer cells in autoimmune blistering diseases. Autoimmunity 45:44-54
97. Geherin SA, Fintushel SR, Lee MH et al (2012) The skin, a novel niche for recirculating B cells. J Immunol 188:6027-6035
98. Mihai S, Nimmerjahn F (2012) The role of Fc receptors and complement in autoimmunity. Autoimmunity reviews 29:266-272
99. Benoit ME, Clarke EV, Morgado P, Fraser DA, Tenner AJ (2012) Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells. J Immunol 188:5682-5693
100. Amezcua Vesely MC, Schwartz M, Bermejo DA et al (2012) FcgammaRIIb and BAFF differentially regulate peritoneal B1 cell survival. J Immunol 188:4792-4800
101. Hirose M, Vafia K, Kalies K et al (2012) Enzymatic autoantibody glycan hydrolysis alleviates autoimmunity against type VII collagen. J Autoimmun 39:304-314
102. Kawata K, Illarionov P, Yang GX et al (2012) Mincle and human B cell function. J Autoimmun 39:315-322
103. Arentz G, Thurgood LA, Lindop R, Chataway TK, Gordon TP (2012) Secreted human Ro52 autoantibody proteomes express a restricted set of public clonotypes. J Autoimmun 39:466-470
104. Aqrawi LA, Brokstad KA, Jakobsen K, Jonsson R, Skarstein K (2012) Low number of memory B cells in the salivary glands of patients with primary Sjogren's syndrome. Autoimmunity 45:547-555
105. Abdulahad WH, Kroese FG, Vissink A, Bootsma H (2012) Immune regulation and B-cell depletion therapy in patients with primary Sjogren's syndrome. J Autoimmun 39:103-111
106. Bombardieri M, Barone F, Lucchesi D et al (2012) Inducible tertiary lymphoid structures, autoimmunity, and exocrine dysfunction in a novel model of salivary gland inflammation in C57BL/6 mice. J Immunol 189:3767-3776
107. Leonardo SM, De Santis JL, Malherbe LP, Gauld SB (2012) Cutting edge: in the absence of regulatory T cells, a unique Th cell population expands and leads to a loss of B cell anergy. J Immunol 188:5223-5226
108. Miwa T, Zhou L, Maldonado MA, Madaio MP, Eisenberg RA, Song WC (2012) Absence of CD59 exacerbates systemic autoimmunity in MRL/lpr mice. J Immunol 189:5434-5441
109. Rankin AL, Guay H, Herber D et al (2012) IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice. J Immunol 188:1656-1667
110. Liubchenko GA, Appleberry HC, Holers VM, Banda NK, Willis VC, Lyubchenko T (2012) Potentially autoreactive naturally occurring transitional T3 B lymphocytes exhibit a unique signaling profile. J Autoimmun 38:293-303
111. Paunovic V, Carter NA, Thalhamer T et al (2012) Immune complex-mediated co-ligation of the BCR with FcgammaRIIB results in homeostatic apoptosis of B cells involving Fas signalling that is defective in the MRL/Lpr model of systemic lupus erythematosus. J Autoimmun 39:332-346
112. Nguyen V, Luzina I, Rus H, Tegla C, Chen C, Rus V (2012) IL-21 promotes lupus-like disease in chronic graft-versus-host disease through both CD4 T cell- and B cell-intrinsic mechanisms. J Immunol 189:1081-1093
113. Lahiri A, Pochard P, Le Pottier L et al (2012) The complexity of the BAFF TNF-family members: implications for autoimmunity. J Autoimmun 39:189-198
114. Mumtaz IM, Hoyer BF, Panne D et al (2012) Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: implications for the treatment of autoimmunity. J Autoimmun 39:180-188
115. Chang SE, Guo L, Tian J et al (2012) Autoimmune bone marrow environment severely inhibits B cell development by inducing extensive cell death and inhibiting proliferation. Autoimmunity 45:210-217
116. Teichmann LL, Kashgarian M, Weaver CT, Roers A, Muller W, Shlomchik MJ (2012) B cell-derived IL-10 does not regulate spontaneous systemic autoimmunity in MRL.Fas(lpr) mice. J Immunol 188:678-685
117. Ray A, Basu S, Williams CB, Salzman NH, Dittel BN (2012) A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand. J Immunol 188:3188-3198
118. Maseda D, Smith SH, DiLillo DJ et al (2012) Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo. J Immunol 188:1036-1048
119. Aringer M, Smolen JS (2012) Therapeutic blockade of TNF in patients with SLE-promising or crazy? Autoimmun Rev 11:321-325
120. Semerano L, Assier E, Boissier MC (2012) Anti-cytokine vaccination: a new biotherapy of autoimmunity? Autoimmun Rev 11:785-786
121. Atzeni F, Talotta R, Salaffi F et al (2012) Immunogenicity and autoimmunity during anti-TNF therapy. Autoimmunity reviews 30:279-300
122. Garg G, Tyler JR, Yang JH et al (2012) Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+ CD25+ regulatory T cell function. J Immunol 188:4644-4653
123. Kornete M, Sgouroudis E, Piccirillo CA (2012) ICOS-dependent homeostasis and function of Foxp3+ regulatory T cells in islets of nonobese diabetic mice. J Immunol 188:1064-1074
124. Quintana FJ, Jin H, Burns EJ et al (2012) Aiolos promotes TH17 differentiation by directly silencing Il2 expression. Nat Immunol 13:770-777
125. Liu X, Alli R, Steeves M, Nguyen P, Vogel P, Geiger TL (2012) The T cell response to IL-10 alters cellular dynamics and paradoxically promotes central nervous system autoimmunity. J Immunol 189:669-678
126. Ireland SJ, Blazek M, Harp CT et al (2012) Antibody-independent B cell effector functions in relapsing remitting multiple sclerosis: clues to increased inflammatory and reduced regulatory B cell capacity. Autoimmunity 45:400-414
127. Jeon EJ, Yoon BY, Lim JY et al (2012) Adoptive transfer of all-trans-retinal-induced regulatory T cells ameliorates experimental autoimmune arthritis in an interferon-gamma knockout model. Autoimmunity 45:460-469
128. Moutsopoulos NM, Kling HM, Angelov N et al (2012) Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis. J Autoimmun 39:294-303
129. Kalinski P (2012) Regulation of immune responses by prostaglandin E2. J Immunol 188:21-28
130. Bahcheli D, Hay V, Nadeau JL, Piccirillo CA (2011) Transfer of cell membrane components via trogocytosis occurs in CD4+ Foxp3+ CD25+ regulatory T-cell contact-dependent suppression. Autoimmunity 44:607-615
131. Dagur PK, Biancotto A, Wei L et al (2011) MCAM-expressing CD4(+) T cells in peripheral blood secrete IL-17A and are significantly elevated in inflammatory autoimmune diseases. J Autoimmun 37:319-327
132. de Lalla C, Rinaldi A, Montagna D et al (2011) Invariant NKT cell reconstitution in pediatric leukemia patients given HLA-haploidentical stem cell transplantation defines distinct CD4+ and CD4- subset dynamics and correlates with remission state. J Immunol 186:4490-4499
133. Dromey JA, Lee BH, Yu H et al (2011) Generation and expansion of regulatory human CD4(+) T-cell clones specific for pancreatic islet autoantigens. J Autoimmun 36:47-55
134. Housley WJ, Adams CO, Vang AG et al (2011) Peroxisome proliferator-activated receptor gamma is required for CD4+ T cell-mediated lymphopenia-associated autoimmunity. J Immunol 187:4161-4169
135. Hoyne GF, Flening E, Yabas M et al (2011) Visualizing the role of Cbl-b in control of islet-reactive CD4 T cells and susceptibility to type 1 diabetes. J Immunol 186:2024-2032
136. Kaminski S, Hermann-Kleiter N, Meisel M et al (2011) Coronin 1A is an essential regulator of the TGFbeta receptor/SMAD3 signaling pathway in Th17 CD4(+) T cells. J Autoimmun 37:198-208
137. Kessel, A., Haj, T., Peri, R., et al. (2011), Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Autoimmun Rev
138. Koh AE, Njoroge SW, Feliu M et al (2011) The SLAM family member CD48 (Slamf2) protects lupus-prone mice from autoimmune nephritis. J Autoimmun 37:48-57
139. Lai W, Yu M, Huang MN, Okoye F, Keegan AD, Farber DL (2011) Transcriptional control of rapid recall by memory CD4 T cells. J Immunol 187:133-140
140. Lalor SJ, Dungan LS, Sutton CE, Basdeo SA, Fletcher JM, Mills KH (2011) Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity. J Immunol 186:5738-5748
141. Long SA, Buckner JH (2011) CD4+ FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game. J Immunol 187:2061-2066
142. Motomura Y, Kitamura H, Hijikata A et al (2011) The transcription factor E4BP4 regulates the production of IL-10 and IL-13 in CD4+ T cells. Nat Immunol 12:450-459
143. Oh HM, Yu CR, Lee Y, Chan CC, Maminishkis A, Egwuagu CE (2011) Autoreactive memory CD4+ T lymphocytes that mediate chronic uveitis reside in the bone marrow through STAT3-dependent mechanisms. J Immunol 187:3338-3346
144. Pepper M, Jenkins MK (2011) Origins of CD4(+) effector and central memory T cells. Nat Immunol 12:467-471
145. Rossi RL, Rossetti G, Wenandy L et al (2011) Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b. Nat Immunol 12:796-803
146. Shameli A, Clemente-Casares X, Wang J, Santamaria P (2011) Development of memory-like autoregulatory CD8+ T cells is CD4+ T cell dependent. J Immunol 187:2859-2866
147. Sun J, Dodd H, Moser EK, Sharma R, Braciale TJ (2011) CD4+ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs. Nat Immunol 12:327-334
148. Tosiek MJ, Gruber AD, Bader SR et al (2011) CD4∈+∈CD25∈ +∈Foxp3+ regulatory T cells are dispensable for controlling CD8+ T cell-mediated lung inflammation. J Immunol 186:6106-6118
149. Tucker CF, Nebane-Ambe DL, Chhabra A et al (2011) Decreased frequencies of CD4∈+∈CD25∈+∈Foxp3+ cells and the potent CD103+ subset in peripheral lymph nodes correlate with autoimmune disease predisposition in some strains of mice. Autoimmunity 44:453-464
150. Yeh WI, McWilliams IL, Harrington LE (2011) Autoreactive Tbet-positive CD4 T cells develop independent of classic Th1 cytokine signaling during experimental autoimmune encephalomyelitis. J Immunol 187:4998-5006
151. Zhou X, Kong N, Zou H et al (2011) Therapeutic potential of TGF-beta-induced CD4(+) Foxp3(+) regulatory T cells in autoimmune diseases. Autoimmunity 44:43-50
152. Maddur MS, Kaveri SV, Bayry J (2011) Comparison of different IVIg preparations on IL-17 production by human Th17 cells. Autoimmun Rev 10:809-810
153. Haylock-Jacobs S, Comerford I, Bunting M et al (2011) PI3Kdelta drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation. J Autoimmun 36:278-287
154. Hickman-Brecks CL, Racz JL, Meyer DM, LaBranche TP, Allen PM (2011) Th17 cells can provide B cell help in autoantibody induced arthritis. J Autoimmun 36:65-75
155. Piconese S, Costanza M, Tripodo C et al (2011) The matricellular protein SPARC supports follicular dendritic cell networking toward Th17 responses. J Autoimmun 37:300-310
156. Wang YL, Chou FC, Chen SJ, Lin SH, Chang DM, Sytwu HK (2011) Targeting pre-ligand assembly domain of TNFR1 ameliorates autoimmune diseases-an unrevealed role in downregulation of Th17 cells. J Autoimmun 37:160-170
157. Carter NA, Vasconcellos R, Rosser EC et al (2011) Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol 186:5569-5579
158. Katzman SD, Gallo E, Hoyer KK, Abbas AK (2011) Differential requirements for Th1 and Th17 responses to a systemic self-antigen. J Immunol 186:4668-4673
159. Lelu K, Laffont S, Delpy L et al (2011) Estrogen receptor alpha signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis. J Immunol 187:2386-2393
160. Pollinger B, Junt T, Metzler B et al (2011) Th17 cells, not IL-17+ gammadelta T cells, drive arthritic bone destruction in mice and humans. J Immunol 186:2602-2612
161. Stoehr AD, Schoen CT, Mertes MM et al (2011) TLR9 in peritoneal B-1b cells is essential for production of protective self-reactive IgM to control Th17 cells and severe autoimmunity. J Immunol 187:2953-2965
162. Krausgruber T, Blazek K, Smallie T et al (2011) IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol 12:231-238
163. Filaci G, Fenoglio D, Indiveri F (2011) CD8(+) T regulatory/suppressor cells and their relationships with autoreactivity and autoimmunity. Autoimmunity 44:51-57
164. Hussain S, Kirwin SJ, Stohlman SA (2011) Increased T regulatory cells lead to development of Th2 immune response in male SJL mice. Autoimmunity 44:219-228
165. Chen M, Felix K, Wang J (2011) Immune regulation through mitochondrion-dependent dendritic cell death induced by T regulatory cells. J Immunol 187:5684-5692
166. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (2011) Pillars article: immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995. J Immunol 186:3808-3821
167. Hegde S, Lockridge JL, Becker YA, Ma S, Kenney SC, Gumperz JE (2011) Human NKT cells direct the differentiation of myeloid APCs that regulate T cell responses via expression of programmed cell death ligands. J Autoimmun 37:28-38
168. Sharma R, Sung SS, Ju CY, Deshmukh US, Fu SM, Ju ST (2011) Regulatory T-Cell (Treg) hybridoma as a novel tool to study Foxp3 regulation and Treg fate. J Autoimmun 37:113-121
169. Yan N, Yu YL, Yang J et al (2012) Association of interleukin-17A and -17F gene single-nucleotide polymorphisms with autoimmune thyroid diseases. Autoimmunity 45:533-539
170. Zhi L, Ustyugova IV, Chen X, Zhang Q, Wu MX (2012) Enhanced Th17 differentiation and aggravated arthritis in IEX-1-deficient mice by mitochondrial reactive oxygen species-mediated signaling. J Immunol 189:1639-1647
171. Liu JQ, Liu Z, Zhang X et al (2012) Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis. J Immunol 188:3099-3106
172. Chang JH, Xiao Y, Hu H et al (2012) Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells. Nat Immunol 13:481-490
173. Chatterjee M, Rauen T, Kis-Toth K et al (2012) Increased expression of SLAM receptors SLAMF3 and SLAMF6 in systemic lupus erythematosus T lymphocytes promotes Th17 differentiation. J Immunol 188:1206-1212
174. Griffin GK, Newton G, Tarrio ML et al (2012) IL-17 and TNF-alpha sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation. J Immunol 188:6287-6299
175. Ioannou M, Alissafi T, Lazaridis I et al (2012) Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease. J Immunol 188:1136-1146
176. Jones SA, Sutton CE, Cua D, Mills KH (2012) Therapeutic potential of targeting IL-17. Nat Immunol 13:1022-1025
177. Joseph J, Bittner S, Kaiser FM, Wiendl H, Kissler S (2012) IL-17 silencing does not protect nonobese diabetic mice from autoimmune diabetes. J Immunol 188:216-221
178. Zhong B, Liu X, Wang X et al (2012) Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25. Nat Immunol 13:1110-1117
179. Chikuma S, Suita N, Okazaki IM, Shibayama S, Honjo T (2012) TRIM28 prevents autoinflammatory T cell development in vivo. Nat Immunol 13:596-603
180. Prado C, Contreras F, Gonzalez H et al (2012) Stimulation of dopamine receptor D5 expressed on dendritic cells potentiates Th17-mediated immunity. J Immunol 188:3062-3070
181. Jagger AL, Evans HG, Walter GJ et al (2012) FAS/FAS-L dependent killing of activated human monocytes and macrophages by CD4+ CD25- responder T cells, but not CD4+ CD25+ regulatory T cells. J Autoimmun 38:29-38
182. Ramaswamy M, Siegel RM (2012) Autoimmunity: twenty years in the Fas lane. J Immunol 189:5097-5100
183. Haque R, Lei F, Xiong X et al (2012) Programming of regulatory T cells from pluripotent stem cells and prevention of autoimmunity. J Immunol 189:1228-1236
184. Tischner D, Gaggl I, Peschel I et al (2012) Defective cell death signalling along the Bcl-2 regulated apoptosis pathway compromises Treg cell development and limits their functionality in mice. J Autoimmun 38:59-69
185. Oh S, Aitken M, Simons DM et al (2012) Requirement for diverse TCR specificities determines regulatory T cell activity in a mouse model of autoimmune arthritis. J Immunol 188:4171-4180
186. Ramalingam R, Larmonier CB, Thurston RD et al (2012) Dendritic cell-specific disruption of TGF-beta receptor II leads to altered regulatory T cell phenotype and spontaneous multiorgan autoimmunity. J Immunol 189:3878-3893
187. Cervantes-Barragan L, Firner S, Bechmann I et al (2012) Regulatory T cells selectively preserve immune privilege of self-antigens during viral central nervous system infection. J Immunol 188:3678-3685
188. Hubner MP, Shi Y, Torrero MN et al (2012) Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-beta. J Immunol 188:559-568
189. Liu Y, Yu Y, Matarese G, La Cava A (2012) Cutting edge: fasting-induced hypoleptinemia expands functional regulatory T cells in systemic lupus erythematosus. J Immunol 188:2070-2073
190. Liu Z, Davidson A (2012) Taming lupus- A new understanding of pathogenesis is leading to clinical advances. Nat Med 18:871-882
191. Ben-Zvi I, Kivity S, Langevitz P, Shoenfeld Y (2012) Hydroxychloroquine: from malaria to autoimmunity. Clin Rev Allergy Immunol 42:145-153
192. Moisini I, Huang W, Bethunaickan R et al (2012) The Yaa locus and IFN-alpha fine-tune germinal center B cell selection in murine systemic lupus erythematosus. J Immunol 189:4305-4312
193. Sawla P, Hossain A, Hahn BH, Singh RP (2012) Regulatory T cells in systemic lupus erythematosus (SLE); role of peptide tolerance. Autoimmun Rev 11:611-614
194. Schall N, Page N, Macri C, Chaloin O, Briand JP, Muller S (2012) Peptide-based approaches to treat lupus and other autoimmune diseases. J Autoimmun 39:143-153
195. Potula HH, Xu Z, Zeumer L, Sang A, Croker BP, Morel L (2012) Cyclin-dependent kinase inhibitor Cdkn2c deficiency promotes B1a cell expansion and autoimmunity in a mouse model of lupus. J Immunol 189:2931-2940
196. Chang C (2012) Neonatal autoimmune diseases: a critical review. J Autoimmun 38:J223-238
197. Doria A, Zen M, Bettio S et al (2012) Autoinflammation and autoimmunity: bridging the divide. Autoimmun Rev 12:22-30
198. Pontillo A, Girardelli M, Kamada AJ et al (2012) Polymorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus. Autoimmunity 45:271-278
199. Shin MS, Kang Y, Lee N et al (2012) U1-small nuclear ribonucleoprotein activates the NLRP3 inflammasome in human monocytes. J Immunol 188:4769-4775
200. Andreoli L, Fredi M, Nalli C et al (2012) Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome. J Autoimmun 38:J197-208
201. Canti V, Castiglioni MT, Rosa S et al (2012) Pregnancy outcomes in patients with systemic autoimmunity. Autoimmunity 45:169-175
202. Sammaritano LR (2012) Menopause in patients with autoimmune diseases. Autoimmun Rev 11:A430-436
203. Barrera MJ, Sanchez M, Aguilera S et al (2012) Aberrant localization of fusion receptors involved in regulated exocytosis in salivary glands of Sjogren's syndrome patients is linked to ectopic mucin secretion. J Autoimmun 39:83-92
204. Selmi C, Meroni PL, Gershwin ME (2012) Primary biliary cirrhosis and Sjogren's syndrome: autoimmune epithelitis. J Autoimmun 39:34-42
205. Pavlakis PP, Alexopoulos H, Kosmidis ML et al (2012) Peripheral neuropathies in Sjogren's syndrome: a critical update on clinical features and pathogenetic mechanisms. J Autoimmun 39:27-33
206. Maugeri N, Franchini S, Campana L et al (2012) Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis. Autoimmunity 45:584-587
207. Shapira Y, Agmon-Levin N, Selmi C et al (2012) Prevalence of anti-Toxoplasma antibodies in patients with autoimmune diseases. J Autoimmun 39:112-116
208. Svyryd Y, Hernandez-Molina G, Vargas F, Sanchez-Guerrero J, Segovia DA, Mutchinick OM (2012) X chromosome monosomy in primary and overlapping autoimmune diseases. Autoimmun Rev 11:301-304
209. Selmi C, Gershwin ME (2012) The long-term marriage between autoimmunity and internal medicine: a homage to Manuel Carlos Dias. Clin Rev Allergy Immunol 43:207-210
210. Moshkani S, Kuzin II, Adewale F et al (2012) CD23+ CD21(high) CD1d(high) B cells in inflamed lymph nodes are a locally differentiated population with increased antigen capture and activation potential. J Immunol 188:5944-5953
211. Lorenzo N, Barbera A, Dominguez MC et al (2012) Therapeutic effect of an altered peptide ligand derived from heat-shock protein 60 by suppressing of inflammatory cytokines secretion in two animal models of rheumatoid arthritis. Autoimmunity 45:449-459
212. Aggarwal A, Sharma A, Bhatnagar A (2012) Bi(o)communications among peripheral blood fractions: A focus on NK and NKT cell biology in rheumatoid arthritis. Autoimmunity 5:5
213. Goldstein BL, Chibnik LB, Karlson EW, Costenbader KH (2012) Epstein-Barr virus serologic abnormalities and risk of rheumatoid arthritis among women. Autoimmunity 45:161-168
214. Hu C, Du W, Zhang X, Wong FS, Wen L (2012) The role of Gr1+ cells after anti-CD20 treatment in type 1 diabetes in nonobese diabetic mice. J Immunol 188:294-301
215. Kadri N, Korpos E, Gupta S et al (2012) CD4(+) type II NKT cells mediate ICOS and programmed death-1-dependent regulation of type 1 diabetes. J Immunol 188:3138-3149
216. Huber AK, Finkelman FD, Li CW et al (2012) Genetically driven target tissue overexpression of CD40: a novel mechanism in autoimmune disease. J Immunol 189:3043-3053
217. Yang H, Wang Z, Xu K et al (2012) IFIH1 gene polymorphisms in type 1 diabetes: genetic association analysis and genotype-phenotype correlation in Chinese Han population. Autoimmunity 45:226-232
218. Nakahara J, Maeda M, Aiso S, Suzuki N (2012) Current concepts in multiple sclerosis: autoimmunity versus oligodendrogliopathy. Clin Rev Allergy Immunol 42:26-34
219. Selmi C, Mix E, Zettl UK (2012) A clear look at the neuroimmunology of multiple sclerosis and beyond. Autoimmun Rev 11:159-162
220. Comi C, Fleetwood T, Dianzani U (2012) The role of T cell apoptosis in nervous system autoimmunity. Autoimmun Rev 12:150-156
221. Gnanapavan S, Grant D, Pryce G, Jackson S, Baker D, Giovannoni G (2012) Neurofilament a biomarker of neurodegeneration in autoimmune encephalomyelitis. Autoimmunity 45:298-303
222. Anderson AC, Chandwaskar R, Lee DH et al (2012) A transgenic model of central nervous system autoimmunity mediated by CD4+ and CD8+ T and B cells. J Immunol 188:2084-2092
223. Kreft KL, Verbraak E, Wierenga-Wolf AF et al (2012) The IL-7Ralpha pathway is quantitatively and functionally altered in CD8 T cells in multiple sclerosis. J Immunol 188:1874-1883
224. Smith KM, Guerau-de-Arellano M, Costinean S et al (2012) miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis. J Immunol 189:1567-1576
225. Anaya JM (2012) Common mechanisms of autoimmune diseases (the autoimmune tautology). Autoimmun Rev 11:781-784
226. Anaya JM, Castiblanco J, Rojas-Villarraga A et al (2012) The multiple autoimmune syndromes. A clue for the autoimmune tautology. Clin Rev Allergy Immunol 43:256-264
227. Anaya JM, Kim-Howard X, Prahalad S et al (2012) Evaluation of genetic association between an ITGAM non-synonymous SNP (rs1143679) and multiple autoimmune diseases. Autoimmun Rev 11:276-280
228. Agmon-Levin N, Theodor E, Segal RM, Shoenfeld Y (2012) Vitamin D in systemic and organ-specific autoimmune diseases. Clin Rev Allergy Immunol 14:14
229. Brooks WH (2012) Mechanisms and pathophysiology of autoimmune disease. Clin Rev Allergy Immunol 42:1-4
230. Shoenfeld Y (2012) The future of autoimmunity. Clin Rev Allergy Immunol 42:113-120